IL‐10 and transforming growth factor‐β (TGF‐β) were found downregulated in OART group, consistent with decreased M2 phenotype TAMs, indicating an immune reverse in tumor microenvironment (Figures 6K and L). The gene discussed is TGFB1; the disease is neoplasm.